CD44 and neoplasm: According to our results, we proposed that: i) Such a “nanoenabled energy interrupter” not only presents a preferential accumulation tendency to tumor sites due to the active CD44‐targeting mechanisms but also specifically releases Zn2+ and DNAzymes controlled by a dual gate (pH and HAase) within tumor cells.